20 participants
Anti-CD5 CAR T Cells for Relapsed/Refractory T Cell Malignancies
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-03-02
- Start Date:
- 2020-12-01
- Completion:
- 2023-11-30
Conditions
- T-cell Acute Lymphoblastic Leukemia
- T-cell Non-Hodgkin Lymphoma
Interventions
- DRUG
No Results Yet